Basic and clinical studies on NM441

We investigated the antibacterial activities and clinical efficacy of NM441, a newly-developed quinolone antibiotic, and the following results were obtained. 1) Antibacterial activities The antibacterial activities of NM394 (active form of NM441) against 150 strains of 6 species were measured. MIC90...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Chemotherapy Vol. 44; no. Supplement1; pp. 289 - 294
Main Authors Sato, Yasunobu, Ishida, Yuichiro, Takahashi, Takayuki, Matsumoto, Fumio, Shimada, Jingoro, Sakurai, Iwao, Nakamura, Toru, Morita, Masayuki, Imai, Takeo
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1996
公益社団法人 日本化学療法学会
Subjects
Online AccessGet full text
ISSN1340-7007
1884-5886
DOI10.11250/chemotherapy1995.44.Supplement1_289

Cover

More Information
Summary:We investigated the antibacterial activities and clinical efficacy of NM441, a newly-developed quinolone antibiotic, and the following results were obtained. 1) Antibacterial activities The antibacterial activities of NM394 (active form of NM441) against 150 strains of 6 species were measured. MIC90s of NM394 against methicillin-susceptible Staphylococcus aureus (MSSA), methicillinresistant S. aureus (MRSA), Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa were 3.13, 6.25, 0.1, 0.2, 0.39 and 3.13μg/ml, respectively. 2) Clinical results Subjects in the clinical study were a total of 10 patients including 5 cases with bacterial pneumonia, 1 with acute bronchitis, 1 with chronic bronchitis, 1 with acute pharyngolaryngitis, 1 with tonsillitis and 1 with acute cystitis. The clinical response was good in 8 cases and fair in 1 of the 9 patients able to be evaluated, and the efficacy rate was 88.9%. In the bacteriological efficacy, S.aureus and α-Streptococcus were isolated from 2 patients with bacterial pneumonia, K.pneumoniae from 1 with acute bronchitis, S.aureus from 1 with chronic bronchitis, Streptococcus pyogenes from 1 with tonsillitis and E. coli from 1 with cystitis, and all isolated organisms were eradicated except S.aureus in bacterial pneumonia and unknown in tonsillitis. Subjective and objective side effects were observed eruption in a patient with tonsillitis, and blister with glossitis in a patient with acute cystitis. From the above results, NM441 showed a wide antibacterial spectrum and good clinical response, and it was considered a useful drug for use in internal medical infections.
ISSN:1340-7007
1884-5886
DOI:10.11250/chemotherapy1995.44.Supplement1_289